H2BC9, which belongs to the H2B aggregator histone gene family, is commonly recognized as a molecular biomarker and an independent prognostic factor for H2BC9 cervical cancer in cervical cancer and glioma (32, 33). The gene discussed is H2BC9; the disease is central nervous system cancer.